kras mutation and glutathion G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Research advances in the treatment
Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine SUN YAT SEN UNIVERSITY Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma Cell Death & Disease
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





